4.7 Article

The use of topiramate in refractory status epilepticus

Journal

NEUROLOGY
Volume 60, Issue 2, Pages 332-334

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/01.WNL.0000042783.86439.27

Keywords

-

Funding

  1. NINDS NIH HHS [P01NS525630] Funding Source: Medline

Ask authors/readers for more resources

In cases of refractory status epilepticus (RSE) unresponsive to sequential trials of multiple agents, a suspension of topiramate administered via nasogastric tube was effective in aborting RSE, including one patient in a prolonged pentobarbital coma. Effective dosages ranged from 300 to 1,600 mg/d. Except for lethargy, no adverse events were reported.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available